533 related articles for article (PubMed ID: 24702624)
1. The potential of targeting Wnt/β-catenin in colon cancer.
Sebio A; Kahn M; Lenz HJ
Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
[TBL] [Abstract][Full Text] [Related]
2. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
4. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.
Manigandan K; Manimaran D; Jayaraj RL; Elangovan N; Dhivya V; Kaphle A
Biochimie; 2015 Dec; 119():103-12. PubMed ID: 26482805
[TBL] [Abstract][Full Text] [Related]
5. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
6. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
Lee MA; Kim WK; Park HJ; Kang SS; Lee SK
Bioorg Med Chem Lett; 2013 Oct; 23(20):5511-4. PubMed ID: 24018191
[TBL] [Abstract][Full Text] [Related]
8. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
9. Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2.
Yan R; Zhu H; Huang P; Yang M; Shen M; Pan Y; Zhang C; Zhou X; Li H; Ke X; Zhang W; Hao P; Qu Y
Cell Rep; 2022 Feb; 38(5):110319. PubMed ID: 35108540
[TBL] [Abstract][Full Text] [Related]
10. 2,3,6-Trisubstituted quinoxaline derivative, a small molecule inhibitor of the Wnt/beta-catenin signaling pathway, suppresses cell proliferation and enhances radiosensitivity in A549/Wnt2 cells.
Lee SB; Gong YD; Park YI; Dong MS
Biochem Biophys Res Commun; 2013 Feb; 431(4):746-52. PubMed ID: 23348226
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
[TBL] [Abstract][Full Text] [Related]
12. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling.
Wu K; Yang Q; Mu Y; Zhou L; Liu Y; Zhou Q; He B
Int J Oncol; 2012 Jul; 41(1):292-8. PubMed ID: 22469784
[TBL] [Abstract][Full Text] [Related]
14. Targeting the canonical Wnt/β-catenin pathway in hematological malignancies.
Ashihara E; Takada T; Maekawa T
Cancer Sci; 2015 Jun; 106(6):665-671. PubMed ID: 25788321
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity.
Bos CL; Diks SH; Hardwick JC; Walburg KV; Peppelenbosch MP; Richel DJ
Carcinogenesis; 2006 Dec; 27(12):2371-82. PubMed ID: 16728434
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Wnt/β-catenin signaling pathway in human cancers.
Yao H; Ashihara E; Maekawa T
Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
[TBL] [Abstract][Full Text] [Related]
18. Polysiphonia japonica extract suppresses the Wnt/beta-catenin pathway in colon cancer cells by activation of NF-kappaB.
Gwak J; Park S; Cho M; Song T; Cha SH; Kim DE; Jeon YJ; Shin JG; Oh S
Int J Mol Med; 2006 Jun; 17(6):1005-10. PubMed ID: 16685408
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]